177 related articles for article (PubMed ID: 32343482)
1. MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice.
Van Nuffel E; Staal J; Baudelet G; Haegman M; Driege Y; Hochepied T; Afonina IS; Beyaert R
EMBO Rep; 2020 Jul; 21(7):e49237. PubMed ID: 32343482
[TBL] [Abstract][Full Text] [Related]
2. Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
Howes A; O'Sullivan PA; Breyer F; Ghose A; Cao L; Krappmann D; Bowcock AM; Ley SC
Biochem J; 2016 Jun; 473(12):1759-68. PubMed ID: 27071417
[TBL] [Abstract][Full Text] [Related]
3. The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes.
Afonina IS; Van Nuffel E; Baudelet G; Driege Y; Kreike M; Staal J; Beyaert R
EMBO Rep; 2016 Jun; 17(6):914-27. PubMed ID: 27113748
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Genetic Heterogeneity of
Israel L; Mellett M
Front Immunol; 2018; 9():2239. PubMed ID: 30386326
[TBL] [Abstract][Full Text] [Related]
5. CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis.
Van Nuffel E; Schmitt A; Afonina IS; Schulze-Osthoff K; Beyaert R; Hailfinger S
J Invest Dermatol; 2017 Mar; 137(3):569-575. PubMed ID: 27939769
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic Abnormalities of Keratinocytes Initiate Skin Inflammation through the IL-23/T17 Axis in a MALT1-Dependent Manner.
Zhang S; Wang M; Wang C; Wang G; Sun K; Xiong S; Cheng L; Yang D; Lin X; Zhao X
J Immunol; 2021 Feb; 206(4):839-848. PubMed ID: 33419765
[TBL] [Abstract][Full Text] [Related]
7. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
Wang M; Zhang S; Zheng G; Huang J; Songyang Z; Zhao X; Lin X
Immunity; 2018 Jul; 49(1):66-79.e5. PubMed ID: 29980436
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte-intrinsic BCL10/MALT1 activity initiates and amplifies psoriasiform skin inflammation.
Kurgyis Z; Vornholz L; Pechloff K; Kemény LV; Wartewig T; Muschaweckh A; Joshi A; Kranen K; Hartjes L; Möckel S; Steiger K; Hameister E; Volz T; Mellett M; French LE; Biedermann T; Korn T; Ruland J
Sci Immunol; 2021 Nov; 6(65):eabi4425. PubMed ID: 34826258
[TBL] [Abstract][Full Text] [Related]
9. Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease.
Mellett M
Cell Immunol; 2020 Aug; 354():104147. PubMed ID: 32593012
[TBL] [Abstract][Full Text] [Related]
10. CARD14
Manils J; Webb LV; Howes A; Janzen J; Boeing S; Bowcock AM; Ley SC
Elife; 2020 Jun; 9():. PubMed ID: 32597759
[TBL] [Abstract][Full Text] [Related]
11. The paracaspase MALT1 in psoriasis.
Hailfinger S; Schulze-Osthoff K
Biol Chem; 2021 Nov; 402(12):1583-1589. PubMed ID: 34192836
[TBL] [Abstract][Full Text] [Related]
12. CARD14/CARMA2 Signaling and its Role in Inflammatory Skin Disorders.
Zotti T; Polvere I; Voccola S; Vito P; Stilo R
Front Immunol; 2018; 9():2167. PubMed ID: 30319628
[TBL] [Abstract][Full Text] [Related]
13. PSORS2 is due to mutations in CARD14.
Jordan CT; Cao L; Roberson ED; Pierson KC; Yang CF; Joyce CE; Ryan C; Duan S; Helms CA; Liu Y; Chen Y; McBride AA; Hwu WL; Wu JY; Chen YT; Menter A; Goldbach-Mansky R; Lowes MA; Bowcock AM
Am J Hum Genet; 2012 May; 90(5):784-95. PubMed ID: 22521418
[TBL] [Abstract][Full Text] [Related]
14. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
Jordan CT; Cao L; Roberson ED; Duan S; Helms CA; Nair RP; Duffin KC; Stuart PE; Goldgar D; Hayashi G; Olfson EH; Feng BJ; Pullinger CR; Kane JP; Wise CA; Goldbach-Mansky R; Lowes MA; Peddle L; Chandran V; Liao W; Rahman P; Krueger GG; Gladman D; Elder JT; Menter A; Bowcock AM
Am J Hum Genet; 2012 May; 90(5):796-808. PubMed ID: 22521419
[TBL] [Abstract][Full Text] [Related]
15. CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17-Mediated Psoriasiform Skin Inflammation In Vivo.
Mellett M; Meier B; Mohanan D; Schairer R; Cheng P; Satoh TK; Kiefer B; Ospelt C; Nobbe S; Thome M; Contassot E; French LE
J Invest Dermatol; 2018 Sep; 138(9):2010-2023. PubMed ID: 29689250
[TBL] [Abstract][Full Text] [Related]
16. CARD14 expression in dermal endothelial cells in psoriasis.
Harden JL; Lewis SM; Pierson KC; Suárez-Fariñas M; Lentini T; Ortenzio FS; Zaba LC; Goldbach-Mansky R; Bowcock AM; Lowes MA
PLoS One; 2014; 9(11):e111255. PubMed ID: 25369198
[TBL] [Abstract][Full Text] [Related]
17. The E3 Ubiquitin Ligase RNF7 Negatively Regulates CARD14/CARMA2sh Signaling.
Telesio G; Scudiero I; Pizzulo M; Mazzone P; Zotti T; Voccola S; Polvere I; Vito P; Stilo R
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194363
[TBL] [Abstract][Full Text] [Related]
18. Gain of function p.E138A alteration in Card14 leads to psoriasiform skin inflammation and implicates genetic modifiers in disease severity.
Sundberg JP; Pratt CH; Silva KA; Kennedy VE; Qin W; Stearns TM; Frost J; Sundberg BA; Bowcock AM
Exp Mol Pathol; 2019 Oct; 110():104286. PubMed ID: 31323190
[TBL] [Abstract][Full Text] [Related]
19. Defining the combinatorial space of PKC::CARD-CC signal transduction nodes.
Staal J; Driege Y; Haegman M; Kreike M; Iliaki S; Vanneste D; Lork M; Afonina IS; Braun H; Beyaert R
FEBS J; 2021 Mar; 288(5):1630-1647. PubMed ID: 32790937
[TBL] [Abstract][Full Text] [Related]
20. A
De Bruyne M; Hoste L; Bogaert DJ; Van den Bossche L; Tavernier SJ; Parthoens E; Migaud M; Konopnicki D; Yombi JC; Lambrecht BN; van Daele S; Alves de Medeiros AK; Brochez L; Beyaert R; De Baere E; Puel A; Casanova JL; Goffard JC; Savvides SN; Haerynck F; Staal J; Dullaers M
Front Immunol; 2018; 9():2366. PubMed ID: 30429846
[No Abstract] [Full Text] [Related]
[Next] [New Search]